nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—CYP2D6—Niacin—atherosclerosis	0.0642	0.106	CbGbCtD
Hydromorphone—CYP2C9—Rosuvastatin—atherosclerosis	0.0597	0.099	CbGbCtD
Hydromorphone—CYP2C9—Simvastatin—atherosclerosis	0.0555	0.0921	CbGbCtD
Hydromorphone—CYP2C9—Pravastatin—atherosclerosis	0.0543	0.0901	CbGbCtD
Hydromorphone—CYP2C9—Lovastatin—atherosclerosis	0.0543	0.0901	CbGbCtD
Hydromorphone—CYP2D6—Simvastatin—atherosclerosis	0.0507	0.0842	CbGbCtD
Hydromorphone—CYP2D6—Pravastatin—atherosclerosis	0.0496	0.0824	CbGbCtD
Hydromorphone—CYP2D6—Lovastatin—atherosclerosis	0.0496	0.0824	CbGbCtD
Hydromorphone—CYP3A4—Rosuvastatin—atherosclerosis	0.0347	0.0576	CbGbCtD
Hydromorphone—CYP3A4—Ezetimibe—atherosclerosis	0.0347	0.0576	CbGbCtD
Hydromorphone—CYP3A4—Simvastatin—atherosclerosis	0.0322	0.0535	CbGbCtD
Hydromorphone—CYP3A4—Pravastatin—atherosclerosis	0.0316	0.0524	CbGbCtD
Hydromorphone—CYP3A4—Lovastatin—atherosclerosis	0.0316	0.0524	CbGbCtD
Hydromorphone—Naloxone—TLR4—atherosclerosis	0.00271	0.712	CrCbGaD
Hydromorphone—Naloxone—ESR1—atherosclerosis	0.00076	0.2	CrCbGaD
Hydromorphone—Eye disorder—Niacin—atherosclerosis	0.000542	0.00215	CcSEcCtD
Hydromorphone—Flatulence—Simvastatin—atherosclerosis	0.000541	0.00215	CcSEcCtD
Hydromorphone—Tinnitus—Niacin—atherosclerosis	0.00054	0.00215	CcSEcCtD
Hydromorphone—Dysgeusia—Simvastatin—atherosclerosis	0.000538	0.00214	CcSEcCtD
Hydromorphone—Flushing—Niacin—atherosclerosis	0.000538	0.00214	CcSEcCtD
Hydromorphone—Angioedema—Lovastatin—atherosclerosis	0.000537	0.00213	CcSEcCtD
Hydromorphone—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000535	0.00213	CcSEcCtD
Hydromorphone—Tinnitus—Pravastatin—atherosclerosis	0.000532	0.00212	CcSEcCtD
Hydromorphone—Malaise—Lovastatin—atherosclerosis	0.00053	0.00211	CcSEcCtD
Hydromorphone—Cardiac disorder—Pravastatin—atherosclerosis	0.00053	0.00211	CcSEcCtD
Hydromorphone—Flushing—Pravastatin—atherosclerosis	0.00053	0.00211	CcSEcCtD
Hydromorphone—Muscle spasms—Simvastatin—atherosclerosis	0.000528	0.0021	CcSEcCtD
Hydromorphone—Vertigo—Lovastatin—atherosclerosis	0.000528	0.0021	CcSEcCtD
Hydromorphone—Angioedema—Ezetimibe—atherosclerosis	0.000526	0.00209	CcSEcCtD
Hydromorphone—Angiopathy—Niacin—atherosclerosis	0.000526	0.00209	CcSEcCtD
Hydromorphone—Leukopenia—Lovastatin—atherosclerosis	0.000526	0.00209	CcSEcCtD
Hydromorphone—Chills—Niacin—atherosclerosis	0.00052	0.00207	CcSEcCtD
Hydromorphone—Malaise—Ezetimibe—atherosclerosis	0.00052	0.00207	CcSEcCtD
Hydromorphone—Vision blurred—Simvastatin—atherosclerosis	0.000518	0.00206	CcSEcCtD
Hydromorphone—Arrhythmia—Niacin—atherosclerosis	0.000518	0.00206	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000515	0.00205	CcSEcCtD
Hydromorphone—Tremor—Simvastatin—atherosclerosis	0.000515	0.00205	CcSEcCtD
Hydromorphone—Chills—Pravastatin—atherosclerosis	0.000512	0.00204	CcSEcCtD
Hydromorphone—Insomnia—Rosuvastatin—atherosclerosis	0.000512	0.00203	CcSEcCtD
Hydromorphone—Ill-defined disorder—Simvastatin—atherosclerosis	0.00051	0.00203	CcSEcCtD
Hydromorphone—Arrhythmia—Pravastatin—atherosclerosis	0.00051	0.00203	CcSEcCtD
Hydromorphone—Palpitations—Ezetimibe—atherosclerosis	0.000509	0.00202	CcSEcCtD
Hydromorphone—Paraesthesia—Rosuvastatin—atherosclerosis	0.000508	0.00202	CcSEcCtD
Hydromorphone—Erythema—Niacin—atherosclerosis	0.000504	0.00201	CcSEcCtD
Hydromorphone—Malnutrition—Niacin—atherosclerosis	0.000504	0.00201	CcSEcCtD
Hydromorphone—Cough—Ezetimibe—atherosclerosis	0.000503	0.002	CcSEcCtD
Hydromorphone—Angioedema—Simvastatin—atherosclerosis	0.000502	0.002	CcSEcCtD
Hydromorphone—Myalgia—Lovastatin—atherosclerosis	0.0005	0.00199	CcSEcCtD
Hydromorphone—Arthralgia—Lovastatin—atherosclerosis	0.0005	0.00199	CcSEcCtD
Hydromorphone—Chest pain—Lovastatin—atherosclerosis	0.0005	0.00199	CcSEcCtD
Hydromorphone—Anxiety—Lovastatin—atherosclerosis	0.000498	0.00198	CcSEcCtD
Hydromorphone—Dyspepsia—Rosuvastatin—atherosclerosis	0.000498	0.00198	CcSEcCtD
Hydromorphone—Hypertension—Ezetimibe—atherosclerosis	0.000497	0.00198	CcSEcCtD
Hydromorphone—Flatulence—Niacin—atherosclerosis	0.000497	0.00198	CcSEcCtD
Hydromorphone—Malaise—Simvastatin—atherosclerosis	0.000495	0.00197	CcSEcCtD
Hydromorphone—Tension—Niacin—atherosclerosis	0.000495	0.00197	CcSEcCtD
Hydromorphone—Discomfort—Lovastatin—atherosclerosis	0.000494	0.00196	CcSEcCtD
Hydromorphone—Vertigo—Simvastatin—atherosclerosis	0.000494	0.00196	CcSEcCtD
Hydromorphone—Leukopenia—Simvastatin—atherosclerosis	0.000492	0.00196	CcSEcCtD
Hydromorphone—Myalgia—Ezetimibe—atherosclerosis	0.00049	0.00195	CcSEcCtD
Hydromorphone—Chest pain—Ezetimibe—atherosclerosis	0.00049	0.00195	CcSEcCtD
Hydromorphone—Arthralgia—Ezetimibe—atherosclerosis	0.00049	0.00195	CcSEcCtD
Hydromorphone—Nervousness—Niacin—atherosclerosis	0.00049	0.00195	CcSEcCtD
Hydromorphone—Flatulence—Pravastatin—atherosclerosis	0.000489	0.00195	CcSEcCtD
Hydromorphone—Dry mouth—Lovastatin—atherosclerosis	0.000489	0.00195	CcSEcCtD
Hydromorphone—Tension—Pravastatin—atherosclerosis	0.000487	0.00194	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000487	0.00194	CcSEcCtD
Hydromorphone—Dysgeusia—Pravastatin—atherosclerosis	0.000486	0.00193	CcSEcCtD
Hydromorphone—Muscle spasms—Niacin—atherosclerosis	0.000485	0.00193	CcSEcCtD
Hydromorphone—Discomfort—Ezetimibe—atherosclerosis	0.000485	0.00193	CcSEcCtD
Hydromorphone—Pain—Rosuvastatin—atherosclerosis	0.000484	0.00192	CcSEcCtD
Hydromorphone—Constipation—Rosuvastatin—atherosclerosis	0.000484	0.00192	CcSEcCtD
Hydromorphone—Confusional state—Lovastatin—atherosclerosis	0.000483	0.00192	CcSEcCtD
Hydromorphone—Nervousness—Pravastatin—atherosclerosis	0.000482	0.00192	CcSEcCtD
Hydromorphone—Dry mouth—Ezetimibe—atherosclerosis	0.00048	0.00191	CcSEcCtD
Hydromorphone—Anaphylactic shock—Lovastatin—atherosclerosis	0.000479	0.00191	CcSEcCtD
Hydromorphone—Muscle spasms—Pravastatin—atherosclerosis	0.000478	0.0019	CcSEcCtD
Hydromorphone—Infection—Lovastatin—atherosclerosis	0.000476	0.00189	CcSEcCtD
Hydromorphone—Vision blurred—Niacin—atherosclerosis	0.000475	0.00189	CcSEcCtD
Hydromorphone—Confusional state—Ezetimibe—atherosclerosis	0.000474	0.00189	CcSEcCtD
Hydromorphone—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00047	0.00187	CcSEcCtD
Hydromorphone—Vision blurred—Pravastatin—atherosclerosis	0.000468	0.00186	CcSEcCtD
Hydromorphone—Arthralgia—Simvastatin—atherosclerosis	0.000468	0.00186	CcSEcCtD
Hydromorphone—Chest pain—Simvastatin—atherosclerosis	0.000468	0.00186	CcSEcCtD
Hydromorphone—Myalgia—Simvastatin—atherosclerosis	0.000468	0.00186	CcSEcCtD
Hydromorphone—Infection—Ezetimibe—atherosclerosis	0.000467	0.00186	CcSEcCtD
Hydromorphone—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000466	0.00185	CcSEcCtD
Hydromorphone—Anxiety—Simvastatin—atherosclerosis	0.000466	0.00185	CcSEcCtD
Hydromorphone—Tremor—Pravastatin—atherosclerosis	0.000465	0.00185	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000463	0.00184	CcSEcCtD
Hydromorphone—Discomfort—Simvastatin—atherosclerosis	0.000462	0.00184	CcSEcCtD
Hydromorphone—Nervous system disorder—Ezetimibe—atherosclerosis	0.000461	0.00183	CcSEcCtD
Hydromorphone—Angioedema—Niacin—atherosclerosis	0.000461	0.00183	CcSEcCtD
Hydromorphone—Ill-defined disorder—Pravastatin—atherosclerosis	0.000461	0.00183	CcSEcCtD
Hydromorphone—Anorexia—Lovastatin—atherosclerosis	0.000457	0.00182	CcSEcCtD
Hydromorphone—Skin disorder—Ezetimibe—atherosclerosis	0.000457	0.00182	CcSEcCtD
Hydromorphone—Angioedema—Pravastatin—atherosclerosis	0.000454	0.00181	CcSEcCtD
Hydromorphone—Vertigo—Niacin—atherosclerosis	0.000453	0.0018	CcSEcCtD
Hydromorphone—Syncope—Niacin—atherosclerosis	0.000452	0.0018	CcSEcCtD
Hydromorphone—Confusional state—Simvastatin—atherosclerosis	0.000452	0.0018	CcSEcCtD
Hydromorphone—Leukopenia—Niacin—atherosclerosis	0.000452	0.0018	CcSEcCtD
Hydromorphone—Urticaria—Rosuvastatin—atherosclerosis	0.000449	0.00179	CcSEcCtD
Hydromorphone—Anaphylactic shock—Simvastatin—atherosclerosis	0.000448	0.00178	CcSEcCtD
Hydromorphone—Malaise—Pravastatin—atherosclerosis	0.000448	0.00178	CcSEcCtD
Hydromorphone—Abdominal pain—Rosuvastatin—atherosclerosis	0.000447	0.00178	CcSEcCtD
Hydromorphone—Vertigo—Pravastatin—atherosclerosis	0.000446	0.00177	CcSEcCtD
Hydromorphone—Palpitations—Niacin—atherosclerosis	0.000446	0.00177	CcSEcCtD
Hydromorphone—Infection—Simvastatin—atherosclerosis	0.000445	0.00177	CcSEcCtD
Hydromorphone—Leukopenia—Pravastatin—atherosclerosis	0.000445	0.00177	CcSEcCtD
Hydromorphone—Loss of consciousness—Niacin—atherosclerosis	0.000443	0.00176	CcSEcCtD
Hydromorphone—Cough—Niacin—atherosclerosis	0.00044	0.00175	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000437	0.00174	CcSEcCtD
Hydromorphone—Insomnia—Lovastatin—atherosclerosis	0.000434	0.00172	CcSEcCtD
Hydromorphone—Cough—Pravastatin—atherosclerosis	0.000433	0.00172	CcSEcCtD
Hydromorphone—Paraesthesia—Lovastatin—atherosclerosis	0.00043	0.00171	CcSEcCtD
Hydromorphone—Arthralgia—Niacin—atherosclerosis	0.000429	0.00171	CcSEcCtD
Hydromorphone—Myalgia—Niacin—atherosclerosis	0.000429	0.00171	CcSEcCtD
Hydromorphone—Hypertension—Pravastatin—atherosclerosis	0.000429	0.00171	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000428	0.0017	CcSEcCtD
Hydromorphone—Anorexia—Simvastatin—atherosclerosis	0.000427	0.0017	CcSEcCtD
Hydromorphone—Dyspnoea—Lovastatin—atherosclerosis	0.000427	0.0017	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000427	0.0017	CcSEcCtD
Hydromorphone—Insomnia—Ezetimibe—atherosclerosis	0.000425	0.00169	CcSEcCtD
Hydromorphone—Myalgia—Pravastatin—atherosclerosis	0.000423	0.00168	CcSEcCtD
Hydromorphone—Arthralgia—Pravastatin—atherosclerosis	0.000423	0.00168	CcSEcCtD
Hydromorphone—Chest pain—Pravastatin—atherosclerosis	0.000423	0.00168	CcSEcCtD
Hydromorphone—Paraesthesia—Ezetimibe—atherosclerosis	0.000422	0.00168	CcSEcCtD
Hydromorphone—Dyspepsia—Lovastatin—atherosclerosis	0.000422	0.00168	CcSEcCtD
Hydromorphone—Anxiety—Pravastatin—atherosclerosis	0.000421	0.00168	CcSEcCtD
Hydromorphone—Dry mouth—Niacin—atherosclerosis	0.00042	0.00167	CcSEcCtD
Hydromorphone—Dyspnoea—Ezetimibe—atherosclerosis	0.000419	0.00167	CcSEcCtD
Hydromorphone—Discomfort—Pravastatin—atherosclerosis	0.000418	0.00166	CcSEcCtD
Hydromorphone—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000417	0.00166	CcSEcCtD
Hydromorphone—Decreased appetite—Lovastatin—atherosclerosis	0.000417	0.00166	CcSEcCtD
Hydromorphone—Dyspepsia—Ezetimibe—atherosclerosis	0.000414	0.00165	CcSEcCtD
Hydromorphone—Fatigue—Lovastatin—atherosclerosis	0.000413	0.00164	CcSEcCtD
Hydromorphone—Anaphylactic shock—Niacin—atherosclerosis	0.000412	0.00164	CcSEcCtD
Hydromorphone—Constipation—Lovastatin—atherosclerosis	0.00041	0.00163	CcSEcCtD
Hydromorphone—Pain—Lovastatin—atherosclerosis	0.00041	0.00163	CcSEcCtD
Hydromorphone—Confusional state—Pravastatin—atherosclerosis	0.000409	0.00163	CcSEcCtD
Hydromorphone—Decreased appetite—Ezetimibe—atherosclerosis	0.000409	0.00163	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000409	0.00162	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000406	0.00161	CcSEcCtD
Hydromorphone—Asthenia—Rosuvastatin—atherosclerosis	0.000406	0.00161	CcSEcCtD
Hydromorphone—Insomnia—Simvastatin—atherosclerosis	0.000406	0.00161	CcSEcCtD
Hydromorphone—Anaphylactic shock—Pravastatin—atherosclerosis	0.000405	0.00161	CcSEcCtD
Hydromorphone—Fatigue—Ezetimibe—atherosclerosis	0.000405	0.00161	CcSEcCtD
Hydromorphone—Shock—Niacin—atherosclerosis	0.000405	0.00161	CcSEcCtD
Hydromorphone—Infection—Pravastatin—atherosclerosis	0.000403	0.0016	CcSEcCtD
Hydromorphone—Paraesthesia—Simvastatin—atherosclerosis	0.000403	0.0016	CcSEcCtD
Hydromorphone—Pain—Ezetimibe—atherosclerosis	0.000402	0.0016	CcSEcCtD
Hydromorphone—Constipation—Ezetimibe—atherosclerosis	0.000402	0.0016	CcSEcCtD
Hydromorphone—Tachycardia—Niacin—atherosclerosis	0.000402	0.0016	CcSEcCtD
Hydromorphone—Pruritus—Rosuvastatin—atherosclerosis	0.0004	0.00159	CcSEcCtD
Hydromorphone—Skin disorder—Niacin—atherosclerosis	0.0004	0.00159	CcSEcCtD
Hydromorphone—Dyspnoea—Simvastatin—atherosclerosis	0.0004	0.00159	CcSEcCtD
Hydromorphone—Hyperhidrosis—Niacin—atherosclerosis	0.000398	0.00158	CcSEcCtD
Hydromorphone—Feeling abnormal—Lovastatin—atherosclerosis	0.000395	0.00157	CcSEcCtD
Hydromorphone—Dyspepsia—Simvastatin—atherosclerosis	0.000395	0.00157	CcSEcCtD
Hydromorphone—Anorexia—Niacin—atherosclerosis	0.000392	0.00156	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000392	0.00156	CcSEcCtD
Hydromorphone—Hyperhidrosis—Pravastatin—atherosclerosis	0.000392	0.00156	CcSEcCtD
Hydromorphone—Decreased appetite—Simvastatin—atherosclerosis	0.00039	0.00155	CcSEcCtD
Hydromorphone—Feeling abnormal—Ezetimibe—atherosclerosis	0.000387	0.00154	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000387	0.00154	CcSEcCtD
Hydromorphone—Diarrhoea—Rosuvastatin—atherosclerosis	0.000387	0.00154	CcSEcCtD
Hydromorphone—Fatigue—Simvastatin—atherosclerosis	0.000387	0.00154	CcSEcCtD
Hydromorphone—Anorexia—Pravastatin—atherosclerosis	0.000386	0.00154	CcSEcCtD
Hydromorphone—Hypotension—Niacin—atherosclerosis	0.000385	0.00153	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000384	0.00153	CcSEcCtD
Hydromorphone—Constipation—Simvastatin—atherosclerosis	0.000383	0.00152	CcSEcCtD
Hydromorphone—Pain—Simvastatin—atherosclerosis	0.000383	0.00152	CcSEcCtD
Hydromorphone—Urticaria—Lovastatin—atherosclerosis	0.000381	0.00151	CcSEcCtD
Hydromorphone—Abdominal pain—Lovastatin—atherosclerosis	0.000379	0.00151	CcSEcCtD
Hydromorphone—Body temperature increased—Lovastatin—atherosclerosis	0.000379	0.00151	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000375	0.00149	CcSEcCtD
Hydromorphone—Dizziness—Rosuvastatin—atherosclerosis	0.000374	0.00149	CcSEcCtD
Hydromorphone—Urticaria—Ezetimibe—atherosclerosis	0.000374	0.00149	CcSEcCtD
Hydromorphone—Insomnia—Niacin—atherosclerosis	0.000372	0.00148	CcSEcCtD
Hydromorphone—Abdominal pain—Ezetimibe—atherosclerosis	0.000372	0.00148	CcSEcCtD
Hydromorphone—Body temperature increased—Ezetimibe—atherosclerosis	0.000372	0.00148	CcSEcCtD
Hydromorphone—Paraesthesia—Niacin—atherosclerosis	0.00037	0.00147	CcSEcCtD
Hydromorphone—Feeling abnormal—Simvastatin—atherosclerosis	0.000369	0.00147	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000369	0.00147	CcSEcCtD
Hydromorphone—Dyspnoea—Niacin—atherosclerosis	0.000367	0.00146	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000367	0.00146	CcSEcCtD
Hydromorphone—Insomnia—Pravastatin—atherosclerosis	0.000367	0.00146	CcSEcCtD
Hydromorphone—Somnolence—Niacin—atherosclerosis	0.000366	0.00146	CcSEcCtD
Hydromorphone—Paraesthesia—Pravastatin—atherosclerosis	0.000364	0.00145	CcSEcCtD
Hydromorphone—Dyspepsia—Niacin—atherosclerosis	0.000362	0.00144	CcSEcCtD
Hydromorphone—Dyspnoea—Pravastatin—atherosclerosis	0.000361	0.00144	CcSEcCtD
Hydromorphone—Decreased appetite—Niacin—atherosclerosis	0.000358	0.00142	CcSEcCtD
Hydromorphone—Dyspepsia—Pravastatin—atherosclerosis	0.000357	0.00142	CcSEcCtD
Hydromorphone—Rash—Rosuvastatin—atherosclerosis	0.000357	0.00142	CcSEcCtD
Hydromorphone—Dermatitis—Rosuvastatin—atherosclerosis	0.000356	0.00142	CcSEcCtD
Hydromorphone—Urticaria—Simvastatin—atherosclerosis	0.000356	0.00142	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Niacin—atherosclerosis	0.000355	0.00141	CcSEcCtD
Hydromorphone—Abdominal pain—Simvastatin—atherosclerosis	0.000354	0.00141	CcSEcCtD
Hydromorphone—Body temperature increased—Simvastatin—atherosclerosis	0.000354	0.00141	CcSEcCtD
Hydromorphone—Headache—Rosuvastatin—atherosclerosis	0.000354	0.00141	CcSEcCtD
Hydromorphone—Hypersensitivity—Lovastatin—atherosclerosis	0.000353	0.0014	CcSEcCtD
Hydromorphone—Decreased appetite—Pravastatin—atherosclerosis	0.000352	0.0014	CcSEcCtD
Hydromorphone—Pain—Niacin—atherosclerosis	0.000352	0.0014	CcSEcCtD
Hydromorphone—Fatigue—Pravastatin—atherosclerosis	0.000349	0.00139	CcSEcCtD
Hydromorphone—Pain—Pravastatin—atherosclerosis	0.000347	0.00138	CcSEcCtD
Hydromorphone—Constipation—Pravastatin—atherosclerosis	0.000347	0.00138	CcSEcCtD
Hydromorphone—Hypersensitivity—Ezetimibe—atherosclerosis	0.000346	0.00138	CcSEcCtD
Hydromorphone—Asthenia—Lovastatin—atherosclerosis	0.000344	0.00137	CcSEcCtD
Hydromorphone—Pruritus—Lovastatin—atherosclerosis	0.000339	0.00135	CcSEcCtD
Hydromorphone—Naloxone—ALB—atherosclerosis	0.000339	0.0888	CrCbGaD
Hydromorphone—Asthenia—Ezetimibe—atherosclerosis	0.000337	0.00134	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Niacin—atherosclerosis	0.000337	0.00134	CcSEcCtD
Hydromorphone—Nausea—Rosuvastatin—atherosclerosis	0.000336	0.00134	CcSEcCtD
Hydromorphone—Feeling abnormal—Pravastatin—atherosclerosis	0.000334	0.00133	CcSEcCtD
Hydromorphone—Pruritus—Ezetimibe—atherosclerosis	0.000333	0.00132	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000331	0.00132	CcSEcCtD
Hydromorphone—Hypersensitivity—Simvastatin—atherosclerosis	0.00033	0.00131	CcSEcCtD
Hydromorphone—Diarrhoea—Lovastatin—atherosclerosis	0.000328	0.0013	CcSEcCtD
Hydromorphone—Urticaria—Niacin—atherosclerosis	0.000327	0.0013	CcSEcCtD
Hydromorphone—Abdominal pain—Niacin—atherosclerosis	0.000325	0.00129	CcSEcCtD
Hydromorphone—Body temperature increased—Niacin—atherosclerosis	0.000325	0.00129	CcSEcCtD
Hydromorphone—Urticaria—Pravastatin—atherosclerosis	0.000322	0.00128	CcSEcCtD
Hydromorphone—Asthenia—Simvastatin—atherosclerosis	0.000322	0.00128	CcSEcCtD
Hydromorphone—Diarrhoea—Ezetimibe—atherosclerosis	0.000322	0.00128	CcSEcCtD
Hydromorphone—Abdominal pain—Pravastatin—atherosclerosis	0.00032	0.00127	CcSEcCtD
Hydromorphone—Body temperature increased—Pravastatin—atherosclerosis	0.00032	0.00127	CcSEcCtD
Hydromorphone—Pruritus—Simvastatin—atherosclerosis	0.000317	0.00126	CcSEcCtD
Hydromorphone—Dizziness—Lovastatin—atherosclerosis	0.000317	0.00126	CcSEcCtD
Hydromorphone—Dizziness—Ezetimibe—atherosclerosis	0.000311	0.00124	CcSEcCtD
Hydromorphone—Diarrhoea—Simvastatin—atherosclerosis	0.000307	0.00122	CcSEcCtD
Hydromorphone—Vomiting—Lovastatin—atherosclerosis	0.000305	0.00121	CcSEcCtD
Hydromorphone—Hypersensitivity—Niacin—atherosclerosis	0.000303	0.00121	CcSEcCtD
Hydromorphone—Rash—Lovastatin—atherosclerosis	0.000302	0.0012	CcSEcCtD
Hydromorphone—Dermatitis—Lovastatin—atherosclerosis	0.000302	0.0012	CcSEcCtD
Hydromorphone—Headache—Lovastatin—atherosclerosis	0.0003	0.00119	CcSEcCtD
Hydromorphone—Vomiting—Ezetimibe—atherosclerosis	0.000299	0.00119	CcSEcCtD
Hydromorphone—Hypersensitivity—Pravastatin—atherosclerosis	0.000299	0.00119	CcSEcCtD
Hydromorphone—Dizziness—Simvastatin—atherosclerosis	0.000297	0.00118	CcSEcCtD
Hydromorphone—Rash—Ezetimibe—atherosclerosis	0.000296	0.00118	CcSEcCtD
Hydromorphone—Dermatitis—Ezetimibe—atherosclerosis	0.000296	0.00118	CcSEcCtD
Hydromorphone—Asthenia—Niacin—atherosclerosis	0.000295	0.00117	CcSEcCtD
Hydromorphone—Headache—Ezetimibe—atherosclerosis	0.000295	0.00117	CcSEcCtD
Hydromorphone—Pruritus—Niacin—atherosclerosis	0.000291	0.00116	CcSEcCtD
Hydromorphone—Asthenia—Pravastatin—atherosclerosis	0.000291	0.00116	CcSEcCtD
Hydromorphone—Pruritus—Pravastatin—atherosclerosis	0.000287	0.00114	CcSEcCtD
Hydromorphone—Vomiting—Simvastatin—atherosclerosis	0.000285	0.00113	CcSEcCtD
Hydromorphone—Nausea—Lovastatin—atherosclerosis	0.000285	0.00113	CcSEcCtD
Hydromorphone—Rash—Simvastatin—atherosclerosis	0.000283	0.00112	CcSEcCtD
Hydromorphone—Dermatitis—Simvastatin—atherosclerosis	0.000282	0.00112	CcSEcCtD
Hydromorphone—Diarrhoea—Niacin—atherosclerosis	0.000282	0.00112	CcSEcCtD
Hydromorphone—Headache—Simvastatin—atherosclerosis	0.000281	0.00112	CcSEcCtD
Hydromorphone—Nausea—Ezetimibe—atherosclerosis	0.000279	0.00111	CcSEcCtD
Hydromorphone—Diarrhoea—Pravastatin—atherosclerosis	0.000277	0.0011	CcSEcCtD
Hydromorphone—Dizziness—Niacin—atherosclerosis	0.000272	0.00108	CcSEcCtD
Hydromorphone—Dizziness—Pravastatin—atherosclerosis	0.000268	0.00107	CcSEcCtD
Hydromorphone—Nausea—Simvastatin—atherosclerosis	0.000266	0.00106	CcSEcCtD
Hydromorphone—Vomiting—Niacin—atherosclerosis	0.000262	0.00104	CcSEcCtD
Hydromorphone—Rash—Niacin—atherosclerosis	0.00026	0.00103	CcSEcCtD
Hydromorphone—Dermatitis—Niacin—atherosclerosis	0.000259	0.00103	CcSEcCtD
Hydromorphone—Headache—Niacin—atherosclerosis	0.000258	0.00103	CcSEcCtD
Hydromorphone—Vomiting—Pravastatin—atherosclerosis	0.000258	0.00103	CcSEcCtD
Hydromorphone—Rash—Pravastatin—atherosclerosis	0.000256	0.00102	CcSEcCtD
Hydromorphone—Dermatitis—Pravastatin—atherosclerosis	0.000255	0.00102	CcSEcCtD
Hydromorphone—Headache—Pravastatin—atherosclerosis	0.000254	0.00101	CcSEcCtD
Hydromorphone—Nausea—Niacin—atherosclerosis	0.000245	0.000973	CcSEcCtD
Hydromorphone—Nausea—Pravastatin—atherosclerosis	0.000241	0.000958	CcSEcCtD
Hydromorphone—CYP2C9—Metabolism—APOA2—atherosclerosis	2.33e-05	0.000164	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	2.33e-05	0.000164	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	2.33e-05	0.000164	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ALOX15—atherosclerosis	2.33e-05	0.000164	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—LEP—atherosclerosis	2.33e-05	0.000164	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—APOE—atherosclerosis	2.33e-05	0.000164	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ABCG5—atherosclerosis	2.32e-05	0.000163	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SOCS3—atherosclerosis	2.31e-05	0.000162	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SPP1—atherosclerosis	2.31e-05	0.000162	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CAV1—atherosclerosis	2.31e-05	0.000162	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ABCG5—atherosclerosis	2.3e-05	0.000162	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.3e-05	0.000162	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—APOA1—atherosclerosis	2.3e-05	0.000162	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—CXCL8—atherosclerosis	2.3e-05	0.000161	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—MTHFR—atherosclerosis	2.27e-05	0.000159	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—LPA—atherosclerosis	2.24e-05	0.000158	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—HMOX1—atherosclerosis	2.24e-05	0.000158	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MMP3—atherosclerosis	2.23e-05	0.000157	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—LPA—atherosclerosis	2.22e-05	0.000156	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PPARA—atherosclerosis	2.22e-05	0.000156	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—ESR1—atherosclerosis	2.22e-05	0.000156	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IGF2—atherosclerosis	2.22e-05	0.000156	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—F2—atherosclerosis	2.19e-05	0.000154	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—BGN—atherosclerosis	2.17e-05	0.000153	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—APOB—atherosclerosis	2.15e-05	0.000151	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—BGN—atherosclerosis	2.15e-05	0.000151	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—AGT—atherosclerosis	2.15e-05	0.000151	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—APOA5—atherosclerosis	2.15e-05	0.000151	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—APOB—atherosclerosis	2.15e-05	0.000151	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.14e-05	0.00015	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—CXCL8—atherosclerosis	2.14e-05	0.00015	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PDGFB—atherosclerosis	2.13e-05	0.00015	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—APOA5—atherosclerosis	2.13e-05	0.00015	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—EDN1—atherosclerosis	2.12e-05	0.000149	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—APOE—atherosclerosis	2.11e-05	0.000148	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCL5—atherosclerosis	2.1e-05	0.000148	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PIK3CG—atherosclerosis	2.1e-05	0.000148	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—CAV1—atherosclerosis	2.09e-05	0.000147	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GSTM1—atherosclerosis	2.09e-05	0.000147	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—APOA1—atherosclerosis	2.08e-05	0.000147	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—AGT—atherosclerosis	2.08e-05	0.000146	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.07e-05	0.000146	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	2.07e-05	0.000146	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—LPL—atherosclerosis	2.06e-05	0.000145	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	2.05e-05	0.000144	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—LPL—atherosclerosis	2.05e-05	0.000144	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—APOE—atherosclerosis	2.04e-05	0.000143	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—LEP—atherosclerosis	2.04e-05	0.000143	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.03e-05	0.000143	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CAV1—atherosclerosis	2.02e-05	0.000142	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—APOA1—atherosclerosis	2.02e-05	0.000142	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—MAPK3—atherosclerosis	2.01e-05	0.000141	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.01e-05	0.000141	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.01e-05	0.000141	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GPX1—atherosclerosis	2e-05	0.000141	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PRKCG—atherosclerosis	2e-05	0.000141	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ALOX5—atherosclerosis	2e-05	0.000141	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—INS—atherosclerosis	1.99e-05	0.00014	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.98e-05	0.000139	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CCL2—atherosclerosis	1.96e-05	0.000137	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—CD36—atherosclerosis	1.95e-05	0.000137	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SPP1—atherosclerosis	1.95e-05	0.000137	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—ESR1—atherosclerosis	1.95e-05	0.000137	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—CXCL8—atherosclerosis	1.94e-05	0.000136	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.94e-05	0.000136	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—F2—atherosclerosis	1.92e-05	0.000135	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IGF1—atherosclerosis	1.92e-05	0.000135	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PIK3CG—atherosclerosis	1.9e-05	0.000134	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—MTHFR—atherosclerosis	1.85e-05	0.00013	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PIK3CG—atherosclerosis	1.84e-05	0.000129	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PPARG—atherosclerosis	1.84e-05	0.000129	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.83e-05	0.000129	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—SERPINE1—atherosclerosis	1.83e-05	0.000128	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—LCAT—atherosclerosis	1.82e-05	0.000128	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—FABP4—atherosclerosis	1.82e-05	0.000128	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PPARA—atherosclerosis	1.81e-05	0.000127	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PDGFB—atherosclerosis	1.8e-05	0.000127	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—INS—atherosclerosis	1.8e-05	0.000127	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.79e-05	0.000126	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—APOA4—atherosclerosis	1.79e-05	0.000126	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—LIPC—atherosclerosis	1.78e-05	0.000125	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.78e-05	0.000125	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—APOC3—atherosclerosis	1.77e-05	0.000124	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.77e-05	0.000124	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—LIPC—atherosclerosis	1.77e-05	0.000124	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—MAPK3—atherosclerosis	1.76e-05	0.000124	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—LDLR—atherosclerosis	1.76e-05	0.000124	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—AGT—atherosclerosis	1.76e-05	0.000124	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—APOC3—atherosclerosis	1.76e-05	0.000123	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.75e-05	0.000123	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—AGT—atherosclerosis	1.75e-05	0.000123	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—LDLR—atherosclerosis	1.75e-05	0.000123	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—NOS3—atherosclerosis	1.74e-05	0.000123	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—INS—atherosclerosis	1.74e-05	0.000123	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—LEP—atherosclerosis	1.72e-05	0.000121	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—APOE—atherosclerosis	1.72e-05	0.000121	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CETP—atherosclerosis	1.72e-05	0.000121	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—APOE—atherosclerosis	1.72e-05	0.000121	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCL2—atherosclerosis	1.71e-05	0.000121	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CAV1—atherosclerosis	1.71e-05	0.00012	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CETP—atherosclerosis	1.7e-05	0.00012	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—APOA1—atherosclerosis	1.7e-05	0.00012	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—CAV1—atherosclerosis	1.7e-05	0.00012	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—APOA1—atherosclerosis	1.7e-05	0.000119	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IGF1—atherosclerosis	1.69e-05	0.000118	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—ALB—atherosclerosis	1.65e-05	0.000116	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.65e-05	0.000116	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ESR1—atherosclerosis	1.65e-05	0.000116	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.63e-05	0.000115	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—F2—atherosclerosis	1.63e-05	0.000114	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.62e-05	0.000114	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SERPINE1—atherosclerosis	1.6e-05	0.000113	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.59e-05	0.000112	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—NOS3—atherosclerosis	1.58e-05	0.000111	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PIK3CG—atherosclerosis	1.56e-05	0.000109	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.55e-05	0.000109	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PIK3CG—atherosclerosis	1.55e-05	0.000109	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CXCL8—atherosclerosis	1.55e-05	0.000109	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.54e-05	0.000108	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.54e-05	0.000108	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—APOA2—atherosclerosis	1.54e-05	0.000108	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.54e-05	0.000108	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.54e-05	0.000108	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—NOS3—atherosclerosis	1.53e-05	0.000107	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.52e-05	0.000107	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PPARG—atherosclerosis	1.5e-05	0.000105	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—AKT1—atherosclerosis	1.49e-05	0.000105	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—MAPK3—atherosclerosis	1.49e-05	0.000105	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—INS—atherosclerosis	1.47e-05	0.000104	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—IL6—atherosclerosis	1.47e-05	0.000103	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—INS—atherosclerosis	1.47e-05	0.000103	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—LPA—atherosclerosis	1.47e-05	0.000103	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCL2—atherosclerosis	1.45e-05	0.000102	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PTGS2—atherosclerosis	1.44e-05	0.000102	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IGF1—atherosclerosis	1.42e-05	0.0001	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—BGN—atherosclerosis	1.42e-05	9.98e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—APOA5—atherosclerosis	1.41e-05	9.88e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MMP9—atherosclerosis	1.4e-05	9.83e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.39e-05	9.77e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.39e-05	9.74e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—NFKB1—atherosclerosis	1.38e-05	9.73e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.37e-05	9.66e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MAPK8—atherosclerosis	1.36e-05	9.56e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—AKT1—atherosclerosis	1.36e-05	9.53e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CXCL8—atherosclerosis	1.36e-05	9.53e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.35e-05	9.51e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SERPINE1—atherosclerosis	1.35e-05	9.51e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ALB—atherosclerosis	1.35e-05	9.46e-05	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—AKT1—atherosclerosis	1.31e-05	9.21e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.31e-05	9.19e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NOS3—atherosclerosis	1.29e-05	9.08e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—IL6—atherosclerosis	1.29e-05	9.06e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—NOS3—atherosclerosis	1.29e-05	9.05e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—VEGFA—atherosclerosis	1.26e-05	8.83e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—STAT3—atherosclerosis	1.24e-05	8.74e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MMP9—atherosclerosis	1.23e-05	8.62e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—NFKB1—atherosclerosis	1.21e-05	8.53e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MAPK8—atherosclerosis	1.19e-05	8.38e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—AKT1—atherosclerosis	1.19e-05	8.36e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.19e-05	8.36e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MAPK3—atherosclerosis	1.19e-05	8.35e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—HMOX1—atherosclerosis	1.18e-05	8.29e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PTGS2—atherosclerosis	1.18e-05	8.28e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.17e-05	8.24e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—LIPC—atherosclerosis	1.17e-05	8.19e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—APOC3—atherosclerosis	1.16e-05	8.14e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TGFB1—atherosclerosis	1.15e-05	8.1e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—LDLR—atherosclerosis	1.15e-05	8.09e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CXCL8—atherosclerosis	1.15e-05	8.05e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—APOB—atherosclerosis	1.14e-05	8.01e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—APOB—atherosclerosis	1.13e-05	7.94e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CETP—atherosclerosis	1.12e-05	7.9e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.11e-05	7.79e-05	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—AKT1—atherosclerosis	1.11e-05	7.78e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—VEGFA—atherosclerosis	1.1e-05	7.74e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTM1—atherosclerosis	1.1e-05	7.72e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—STAT3—atherosclerosis	1.09e-05	7.66e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—IL6—atherosclerosis	1.09e-05	7.66e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—LPL—atherosclerosis	1.09e-05	7.64e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—LPL—atherosclerosis	1.08e-05	7.58e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.08e-05	7.57e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GPX1—atherosclerosis	1.06e-05	7.46e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GPX1—atherosclerosis	1.05e-05	7.39e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MAPK3—atherosclerosis	1.04e-05	7.32e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MMP9—atherosclerosis	1.04e-05	7.28e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CD36—atherosclerosis	1.03e-05	7.26e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NFKB1—atherosclerosis	1.03e-05	7.21e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CD36—atherosclerosis	1.02e-05	7.2e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.02e-05	7.15e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TGFB1—atherosclerosis	1.01e-05	7.1e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MAPK8—atherosclerosis	1.01e-05	7.08e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—AKT1—atherosclerosis	1.01e-05	7.07e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—MTHFR—atherosclerosis	9.79e-06	6.88e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—MTHFR—atherosclerosis	9.71e-06	6.82e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PPARA—atherosclerosis	9.61e-06	6.75e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PPARA—atherosclerosis	9.52e-06	6.69e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—VEGFA—atherosclerosis	9.31e-06	6.54e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—AGT—atherosclerosis	9.3e-06	6.54e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—AGT—atherosclerosis	9.22e-06	6.48e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—STAT3—atherosclerosis	9.21e-06	6.48e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—APOE—atherosclerosis	9.12e-06	6.41e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ABCA1—atherosclerosis	9.06e-06	6.37e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—APOE—atherosclerosis	9.04e-06	6.35e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CAV1—atherosclerosis	9.03e-06	6.35e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—APOA1—atherosclerosis	9.01e-06	6.33e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CAV1—atherosclerosis	8.95e-06	6.29e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—APOA1—atherosclerosis	8.93e-06	6.28e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MAPK3—atherosclerosis	8.8e-06	6.19e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL6—atherosclerosis	8.69e-06	6.1e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TGFB1—atherosclerosis	8.54e-06	6e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3CG—atherosclerosis	8.23e-06	5.78e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3CG—atherosclerosis	8.16e-06	5.73e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—AKT1—atherosclerosis	8.01e-06	5.63e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PPARG—atherosclerosis	7.94e-06	5.58e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PPARG—atherosclerosis	7.87e-06	5.53e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—INS—atherosclerosis	7.79e-06	5.47e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HMOX1—atherosclerosis	7.77e-06	5.46e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—INS—atherosclerosis	7.72e-06	5.43e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL6—atherosclerosis	7.62e-06	5.35e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—APOB—atherosclerosis	7.45e-06	5.23e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—AKT1—atherosclerosis	7.26e-06	5.1e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTM1—atherosclerosis	7.24e-06	5.09e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ALB—atherosclerosis	7.14e-06	5.02e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—LPL—atherosclerosis	7.11e-06	5e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ALB—atherosclerosis	7.08e-06	4.97e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—AKT1—atherosclerosis	7.03e-06	4.94e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GPX1—atherosclerosis	6.94e-06	4.88e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—NOS3—atherosclerosis	6.83e-06	4.8e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—NOS3—atherosclerosis	6.77e-06	4.76e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CD36—atherosclerosis	6.76e-06	4.75e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL6—atherosclerosis	6.44e-06	4.52e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—MTHFR—atherosclerosis	6.4e-06	4.5e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PPARA—atherosclerosis	6.28e-06	4.41e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PTGS2—atherosclerosis	6.25e-06	4.39e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PTGS2—atherosclerosis	6.19e-06	4.35e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—AGT—atherosclerosis	6.08e-06	4.28e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—APOE—atherosclerosis	5.96e-06	4.19e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—AKT1—atherosclerosis	5.94e-06	4.17e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—AKT1—atherosclerosis	5.92e-06	4.16e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CAV1—atherosclerosis	5.91e-06	4.15e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—APOA1—atherosclerosis	5.89e-06	4.14e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3CG—atherosclerosis	5.38e-06	3.78e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PPARG—atherosclerosis	5.19e-06	3.65e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—INS—atherosclerosis	5.09e-06	3.58e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALB—atherosclerosis	4.67e-06	3.28e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NOS3—atherosclerosis	4.47e-06	3.14e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PTGS2—atherosclerosis	4.08e-06	2.87e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—AKT1—atherosclerosis	3.14e-06	2.21e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—AKT1—atherosclerosis	3.11e-06	2.19e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—AKT1—atherosclerosis	2.05e-06	1.44e-05	CbGpPWpGaD
